Cargando…
Treatment of steroid‐resistant checkpoint inhibitor pneumonitis with pirfenidone: A case report
With the increased use of immune checkpoint inhibitors (ICIs) in lung cancer, which are of great benefit to patients, more and more immune‐related adverse events (irAEs) are being reported. Checkpoint inhibitor pneumonitis (CIP) is one of the most challenging adverse events, which pose a huge challe...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327698/ https://www.ncbi.nlm.nih.gov/pubmed/34145962 http://dx.doi.org/10.1111/1759-7714.13921 |